Elanco Animal Health Inc 4

EVP and CFO Robert M. VanHimbergen received 7.938 deferred stock units of Elanco Animal Health Inc. common stock as a small routine equity-based award.

On July 10, 2026, Elanco Animal Health Inc. EVP and CFO Robert M. VanHimbergen was granted 7.938 deferred stock units at an implied value of approximately $24.82 per unit (about $197 in total), which correspond to an equivalent number of shares of common stock and will settle in cash or stock following termination of employment or at a specified future date under the company’s Executive Deferral and Stock Match Plan. Following this small, routine compensation-related award, VanHimbergen beneficially owns 7.938 shares’ worth of common stock on a deferred basis, with an estimated current market value of roughly $200 based on the recent trading price of Elanco shares.

Filing Facts

CIK

1739104

Ticker

ELAN

Form

4

Source Type

fda

Accession

0001724169-26-000033

Alert Tier

4